Venny Beauty, Ninik Sukartini


The use of glucometers has been widely recommended to help patients in controlling their blood glucose level. This study compared the blood glucose level measured by Contour® Plus glucometer and Cobas c501 chemistry analyzer, as the reference method. The study design was cross-sectional and conducted in the Dr. Cipto Mangunkusumo Hospital in April 2017. Study materials were 120 capillary blood examined by Contour® Plus glucometer and plasma analyzed by Cobas c501 chemistry analyzer. Precision, correlation, accuracy, and clinical accuracy tests were performed based on ISO 15197:2013, using Parkes error grid analysis. Contour® Plus glucometer yielded a CV of 1.56-2.2%, following the recommendation of the American Diabetes Association, of <5%, there was a strong positive correlation between the glucose level of capillary blood and plasma (r=0.997). Accuracy test based on ISO 15197:2013 showed that 100% of capillary blood glucose deviations were within the ±15 mg/dL range for glucose level <100 mg/dL and ±15% range for glucose level ≥100 mg/dL. Clinical accuracy test with Parkes error grid showed 100% of results were in zone A. Contour® Plus glucometer test results met the ISO 15197:2013 criteria, so the results were proportional to the reference method’s results and clinically acceptable. Contour® Plus glucometer is safe to be used in blood glucose monitoring, as long as careful attention is given to the device specifications.


Blood glucose, diabetes mellitus, glucometer

Full Text:



Powers AC. Diabetes mellitus: Diagnosis, classification, and pathophysiology. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s principle of internal medicine. 19th Ed., New York, McGraw Hill, 2015; 2399-407.

World Health Organization. Global burden on diabetes, 2016; 1-86.

Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan. Riset kesehatan dasar 2013. Jakarta, Badan Litbangkes Kemenkes RI, 2013; 1-306.

Deepa DV, Kiran BR, Gadwalkar SR. Macrovascular and microvascular complications in newly diagnosed type 2 diabetes mellitus. Indian Journal of Clinical Practice, 2014; 25(7): 644-8.

Sacks DB. Diabetes mellitus. In: Rifai N, Horvath AR, Wittwer CT. Tietz textbook of clinical chemistry and molecular diagnostics. 6th Ed., Missouri, Elsevier Saunders, 2018; 1160-99.

Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, et al. Clinical utility of SMBG: Recommendations on the use and reporting of SMBG in clinical research. Diabetes Care 2015; 38: 1627-33.

Wallymahmed M. Encouraging people with diabetes to get the most from blood glucose monitoring: Observing and acting upon blood glucose patterns. J Diabetes Nurs 2013; 17: 6-13.

Schnell O, Hanefeld M, Monnier L. Self-monitoring of blood glucose: A prerequisite for diabetes management in outcome trials. J Diabetes Sci Technol, 2014; 8(3): 609-14.

Leaflet Contour® Plus. Bayer. 2012.

International Organization for Standardization. In vitro diagnostic test system requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2013(E). Switzerland 2013.

Huang TY, Chang HW, Tsao MF, Chuang SM, Ni CC, et al. Evaluation of accuracy of FAD-GDH- and mutant Q-GDH- based blood glucose monitors in multi-patient populations. Clin Chim Acta. 2014; 433: 28-33.

Leaflet GLUC 2 Automated Chemical Analyzer Cobas c501. PT Roche Indonesia. 2010.

Walsh J, Roberts R, Vigersky RA, Schwartz F. New criteria for assessing the accuracy of blood glucose monitors meeting. J Diabetes Sci Technol, 2012; 6(2): 466-74.

Kapusta M, Slowinska-Solnica, Skupien J, Malecki MT, Solnica B. Analytical evaluation of the Contour® Plus Glucose Meter. Diabetologia Kliniczna, 2014; 3(2): 62-8.

Dunne N, Viggiani MT, Pardo S, Robinson C, Parkes JL. Accuracy evaluation of Contour Plus compared with four blood glucose monitoring systems. Diabetes Ther, 2015; 6: 377-88.

DOI: http://dx.doi.org/10.24293/ijcpml.v24i3.1340


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.